Catalyst Wire Dossier Catalyst Wire Dossier

LIALDA

mesalamine · Takeda Pharmaceuticals America, Inc.
Drug timelines are a Plus or Pro feature.

21 regulatory and trial events tracked for LIALDA, covering 2007-01-16 to 2023-10-24. Get the full timeline:

Most recent: FDA Approved: LIALDA — Supplemental Application (Takeda Pharmaceuticals America, Inc.)

See pricing